TY - JOUR
T1 - Knowledge of cervical cancer prevention and human papillomavirus among women with HIV
AU - Massad, L. Stewart
AU - Evans, Charlesnika T.
AU - Wilson, Tracey E.
AU - Goderre, Johanna L.
AU - Hessol, Nancy A.
AU - Henry, Donna
AU - Colie, Christine
AU - Strickler, Howard D.
AU - Levine, Alexandra M.
AU - Watts, D. Heather
AU - Weber, Kathleen M.
PY - 2010/4/1
Y1 - 2010/4/1
N2 - Objective: To assess knowledge of and attitudes towards human papillomavirus (HPV), Pap testing, and the HPV vaccine. Methods: In a multicenter U.S. cohort study, women with the human immunodeficiency virus (HIV) and at-risk comparison women completed 44-item standardized self-report questionnaires exploring their knowledge of cervical cancer prevention, HPV, and HPV vaccination. Results were correlated with demographic variables, measures of education and attention, and medical factors. Data were clustered using principal component analysis. Significant associations were assessed in multivariable models. Results: Among 1588 women, HIV seropositive women better understood facts about cervical cancer prevention and HPV than seronegative women, but both had substantial knowledge deficits. Almost all women considered Pap testing important, although 53% of HIV seropositive and 48% of seronegative women considered cervical cancer not preventable (P = 0.21). Only 44% of HIV seropositive women knew Paps assess the cervix, versus 42% of HIV seronegative women (P = 0.57). Both groups understood that HPV causes genital warts and cervical cancer (67% of HIV seropositive vs. 55% of seronegative women, P = 0.002). About half of both groups considered HPV vaccination extremely important for cervical cancer prevention. HIV seronegative women were more likely to report learning of HPV vaccination through advertising than from clinicians (81% vs. 64%, P < 0.0001). Conclusion: High risk women need effective education about cervical cancer prevention, HPV, and HPV vaccination.
AB - Objective: To assess knowledge of and attitudes towards human papillomavirus (HPV), Pap testing, and the HPV vaccine. Methods: In a multicenter U.S. cohort study, women with the human immunodeficiency virus (HIV) and at-risk comparison women completed 44-item standardized self-report questionnaires exploring their knowledge of cervical cancer prevention, HPV, and HPV vaccination. Results were correlated with demographic variables, measures of education and attention, and medical factors. Data were clustered using principal component analysis. Significant associations were assessed in multivariable models. Results: Among 1588 women, HIV seropositive women better understood facts about cervical cancer prevention and HPV than seronegative women, but both had substantial knowledge deficits. Almost all women considered Pap testing important, although 53% of HIV seropositive and 48% of seronegative women considered cervical cancer not preventable (P = 0.21). Only 44% of HIV seropositive women knew Paps assess the cervix, versus 42% of HIV seronegative women (P = 0.57). Both groups understood that HPV causes genital warts and cervical cancer (67% of HIV seropositive vs. 55% of seronegative women, P = 0.002). About half of both groups considered HPV vaccination extremely important for cervical cancer prevention. HIV seronegative women were more likely to report learning of HPV vaccination through advertising than from clinicians (81% vs. 64%, P < 0.0001). Conclusion: High risk women need effective education about cervical cancer prevention, HPV, and HPV vaccination.
KW - Cervical cancer prevention
KW - HIV in women
KW - HPV
KW - Health education
KW - Pap test
UR - http://www.scopus.com/inward/record.url?scp=77949310953&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=77949310953&partnerID=8YFLogxK
U2 - 10.1016/j.ygyno.2009.12.030
DO - 10.1016/j.ygyno.2009.12.030
M3 - Article
C2 - 20106513
AN - SCOPUS:77949310953
VL - 117
SP - 70
EP - 76
JO - Gynecologic Oncology
JF - Gynecologic Oncology
SN - 0090-8258
IS - 1
ER -